Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Notch | 21 | 2021 | 204 | 5.320 |
Why?
|
| Drosophila Proteins | 26 | 2020 | 780 | 4.250 |
Why?
|
| Glucosyltransferases | 15 | 2025 | 44 | 4.080 |
Why?
|
| Drosophila | 17 | 2023 | 795 | 3.440 |
Why?
|
| Alagille Syndrome | 4 | 2025 | 54 | 2.750 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 5 | 2022 | 11 | 2.220 |
Why?
|
| Liver | 6 | 2025 | 1799 | 2.110 |
Why?
|
| Congenital Disorders of Glycosylation | 3 | 2022 | 48 | 2.040 |
Why?
|
| Signal Transduction | 24 | 2025 | 4683 | 1.980 |
Why?
|
| Drosophila melanogaster | 14 | 2022 | 846 | 1.810 |
Why?
|
| Glycosyltransferases | 6 | 2025 | 26 | 1.600 |
Why?
|
| Polysaccharides | 4 | 2021 | 142 | 1.490 |
Why?
|
| Epidermal Growth Factor | 4 | 2018 | 116 | 1.180 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 5 | 2023 | 293 | 1.180 |
Why?
|
| Animals | 47 | 2025 | 34404 | 1.020 |
Why?
|
| Glycosylation | 11 | 2021 | 122 | 1.000 |
Why?
|
| SOX9 Transcription Factor | 3 | 2025 | 91 | 0.990 |
Why?
|
| Serrate-Jagged Proteins | 5 | 2023 | 36 | 0.950 |
Why?
|
| Jagged-1 Protein | 7 | 2025 | 53 | 0.940 |
Why?
|
| SOXC Transcription Factors | 1 | 2025 | 12 | 0.920 |
Why?
|
| Muscle Development | 1 | 2025 | 71 | 0.900 |
Why?
|
| N-Acetylglucosaminyltransferases | 3 | 2019 | 12 | 0.860 |
Why?
|
| Dependovirus | 1 | 2025 | 157 | 0.820 |
Why?
|
| Lipolysis | 1 | 2023 | 76 | 0.800 |
Why?
|
| Membrane Proteins | 8 | 2023 | 1610 | 0.790 |
Why?
|
| Wings, Animal | 3 | 2017 | 30 | 0.790 |
Why?
|
| Pentosyltransferases | 3 | 2018 | 18 | 0.770 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2023 | 73 | 0.760 |
Why?
|
| Bile Ducts | 2 | 2020 | 53 | 0.740 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2022 | 22 | 0.730 |
Why?
|
| Calcium-Binding Proteins | 4 | 2023 | 328 | 0.700 |
Why?
|
| Transcription Factors | 6 | 2017 | 2438 | 0.660 |
Why?
|
| Genetic Therapy | 1 | 2025 | 726 | 0.640 |
Why?
|
| Fucosyltransferases | 1 | 2019 | 25 | 0.620 |
Why?
|
| Protein Kinases | 2 | 2020 | 322 | 0.610 |
Why?
|
| Genetic Background | 1 | 2018 | 7 | 0.590 |
Why?
|
| Glycomics | 1 | 2018 | 16 | 0.580 |
Why?
|
| Liver Diseases | 2 | 2019 | 382 | 0.570 |
Why?
|
| Translocation, Genetic | 1 | 2020 | 350 | 0.560 |
Why?
|
| Glycoproteins | 1 | 2020 | 349 | 0.560 |
Why?
|
| Xylose | 2 | 2017 | 6 | 0.540 |
Why?
|
| Imaginal Discs | 1 | 2017 | 10 | 0.530 |
Why?
|
| Heterozygote | 2 | 2020 | 728 | 0.520 |
Why?
|
| Sense Organs | 4 | 2006 | 18 | 0.500 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2017 | 126 | 0.500 |
Why?
|
| Rare Diseases | 1 | 2018 | 208 | 0.490 |
Why?
|
| Transgenes | 4 | 2014 | 323 | 0.490 |
Why?
|
| Bile Duct Diseases | 1 | 2015 | 16 | 0.470 |
Why?
|
| Mice | 13 | 2025 | 18482 | 0.460 |
Why?
|
| Gene Silencing | 3 | 2025 | 230 | 0.450 |
Why?
|
| Photoreceptor Cells | 1 | 2014 | 91 | 0.430 |
Why?
|
| Phenotype | 6 | 2025 | 4528 | 0.420 |
Why?
|
| Retinitis Pigmentosa | 1 | 2014 | 89 | 0.410 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 568 | 0.410 |
Why?
|
| Eye Proteins | 1 | 2014 | 234 | 0.400 |
Why?
|
| Satellite Cells, Skeletal Muscle | 3 | 2025 | 37 | 0.390 |
Why?
|
| Gene Deletion | 1 | 2015 | 773 | 0.380 |
Why?
|
| Repetitive Sequences, Amino Acid | 3 | 2019 | 18 | 0.370 |
Why?
|
| Nuclear Proteins | 5 | 2006 | 1226 | 0.370 |
Why?
|
| Mutation | 13 | 2020 | 6194 | 0.340 |
Why?
|
| Gene Expression Regulation | 6 | 2020 | 2353 | 0.330 |
Why?
|
| Stem Cells | 3 | 2025 | 713 | 0.330 |
Why?
|
| Cell Differentiation | 4 | 2025 | 1948 | 0.310 |
Why?
|
| Genetic Techniques | 1 | 2010 | 99 | 0.300 |
Why?
|
| Embryonic Development | 1 | 2011 | 225 | 0.300 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 2 | 2020 | 27 | 0.290 |
Why?
|
| Humans | 23 | 2025 | 131759 | 0.280 |
Why?
|
| Bile Ducts, Intrahepatic | 2 | 2023 | 104 | 0.270 |
Why?
|
| Ligands | 3 | 2018 | 486 | 0.270 |
Why?
|
| Genes, Insect | 2 | 2008 | 113 | 0.250 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 4685 | 0.250 |
Why?
|
| Muscle, Skeletal | 2 | 2025 | 1004 | 0.250 |
Why?
|
| Endocytosis | 2 | 2005 | 129 | 0.240 |
Why?
|
| Receptor, Notch2 | 1 | 2025 | 12 | 0.230 |
Why?
|
| Receptor, Notch3 | 1 | 2025 | 12 | 0.230 |
Why?
|
| PAX7 Transcription Factor | 1 | 2025 | 21 | 0.230 |
Why?
|
| Myoblasts | 1 | 2025 | 34 | 0.230 |
Why?
|
| Glucose | 4 | 2014 | 848 | 0.230 |
Why?
|
| Receptor, Notch1 | 1 | 2025 | 75 | 0.230 |
Why?
|
| Neurons | 5 | 2006 | 1995 | 0.220 |
Why?
|
| Cell Lineage | 2 | 2006 | 349 | 0.220 |
Why?
|
| Vesicular Transport Proteins | 1 | 2005 | 140 | 0.220 |
Why?
|
| Zinc Fingers | 1 | 2004 | 119 | 0.210 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2017 | 1005 | 0.210 |
Why?
|
| Cell Proliferation | 3 | 2025 | 2483 | 0.200 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2004 | 104 | 0.200 |
Why?
|
| Oocytes | 1 | 2005 | 283 | 0.200 |
Why?
|
| DNA-Binding Proteins | 6 | 2005 | 1965 | 0.200 |
Why?
|
| Fibroblasts | 3 | 2020 | 864 | 0.200 |
Why?
|
| Enterocytes | 1 | 2023 | 68 | 0.200 |
Why?
|
| Juvenile Hormones | 1 | 2002 | 4 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 4768 | 0.180 |
Why?
|
| Body Patterning | 1 | 2002 | 128 | 0.180 |
Why?
|
| Repressor Proteins | 5 | 2008 | 781 | 0.180 |
Why?
|
| Cell Line | 6 | 2017 | 2606 | 0.180 |
Why?
|
| Mice, Knockout | 2 | 2025 | 3864 | 0.180 |
Why?
|
| Epithelial Cells | 1 | 2006 | 900 | 0.180 |
Why?
|
| Genetic Vectors | 1 | 2025 | 901 | 0.180 |
Why?
|
| NF-E2-Related Factor 1 | 1 | 2020 | 8 | 0.170 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 2363 | 0.170 |
Why?
|
| Cholestasis | 1 | 2023 | 165 | 0.170 |
Why?
|
| Adipose Tissue | 1 | 2023 | 495 | 0.160 |
Why?
|
| Dystroglycans | 1 | 2020 | 7 | 0.160 |
Why?
|
| Lipids | 1 | 2023 | 565 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 5 | 2015 | 723 | 0.150 |
Why?
|
| Cell Transdifferentiation | 1 | 2020 | 58 | 0.150 |
Why?
|
| Mass Spectrometry | 2 | 2018 | 359 | 0.150 |
Why?
|
| Portal Vein | 1 | 2019 | 88 | 0.140 |
Why?
|
| Hepatocytes | 1 | 2020 | 234 | 0.140 |
Why?
|
| Cell Aggregation | 1 | 2018 | 20 | 0.140 |
Why?
|
| Protein Binding | 4 | 2017 | 1712 | 0.140 |
Why?
|
| Base Sequence | 3 | 2014 | 2783 | 0.130 |
Why?
|
| Carrier Proteins | 1 | 2002 | 1024 | 0.130 |
Why?
|
| Nervous System | 3 | 2006 | 123 | 0.130 |
Why?
|
| Protein Folding | 2 | 2015 | 215 | 0.120 |
Why?
|
| Peptide Mapping | 1 | 2016 | 40 | 0.120 |
Why?
|
| Muscular Dystrophies | 1 | 2016 | 52 | 0.120 |
Why?
|
| Mutation, Missense | 2 | 2018 | 933 | 0.120 |
Why?
|
| Cells, Cultured | 2 | 2020 | 2969 | 0.120 |
Why?
|
| Animals, Genetically Modified | 3 | 2020 | 331 | 0.120 |
Why?
|
| Energy Metabolism | 1 | 2020 | 785 | 0.120 |
Why?
|
| Growth and Development | 1 | 2015 | 21 | 0.120 |
Why?
|
| Hepatic Insufficiency | 1 | 2015 | 2 | 0.120 |
Why?
|
| Molecular Sequence Data | 6 | 2007 | 3616 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 432 | 0.110 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2015 | 31 | 0.110 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 225 | 0.110 |
Why?
|
| Amino Acid Sequence | 5 | 2008 | 2565 | 0.110 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 253 | 0.110 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2015 | 41 | 0.110 |
Why?
|
| Enzyme Assays | 2 | 2015 | 11 | 0.110 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 1844 | 0.110 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 122 | 0.110 |
Why?
|
| Recombination, Genetic | 2 | 2014 | 426 | 0.100 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2015 | 137 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2014 | 300 | 0.100 |
Why?
|
| Temperature | 2 | 2011 | 294 | 0.100 |
Why?
|
| Peptides | 1 | 2016 | 835 | 0.090 |
Why?
|
| Models, Biological | 5 | 2014 | 1395 | 0.090 |
Why?
|
| Biomarkers | 1 | 2022 | 3407 | 0.090 |
Why?
|
| Receptors, Serotonin | 2 | 2003 | 37 | 0.090 |
Why?
|
| Factor VII | 1 | 2011 | 17 | 0.090 |
Why?
|
| Embryo, Nonmammalian | 3 | 2008 | 145 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 3093 | 0.090 |
Why?
|
| Genome, Insect | 1 | 2011 | 81 | 0.080 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2011 | 53 | 0.080 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 366 | 0.080 |
Why?
|
| RNA Interference | 2 | 2008 | 496 | 0.080 |
Why?
|
| Developmental Disabilities | 1 | 2015 | 771 | 0.080 |
Why?
|
| Seizures | 1 | 2015 | 890 | 0.080 |
Why?
|
| Gene Dosage | 1 | 2011 | 439 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 2 | 2005 | 1130 | 0.070 |
Why?
|
| Apoptosis | 2 | 2005 | 1861 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 356 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 275 | 0.070 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2007 | 41 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2011 | 2569 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 803 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2006 | 625 | 0.060 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 2005 | 3 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 1610 | 0.060 |
Why?
|
| Trans-Activators | 2 | 2006 | 692 | 0.060 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2005 | 51 | 0.060 |
Why?
|
| Golgi Apparatus | 1 | 2005 | 92 | 0.060 |
Why?
|
| Abnormalities, Multiple | 1 | 2011 | 974 | 0.060 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2004 | 29 | 0.060 |
Why?
|
| Transcription, Genetic | 3 | 2007 | 1398 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2005 | 129 | 0.050 |
Why?
|
| Protein Transport | 1 | 2005 | 362 | 0.050 |
Why?
|
| Raphe Nuclei | 2 | 2003 | 16 | 0.050 |
Why?
|
| Infant | 1 | 2020 | 13317 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 794 | 0.050 |
Why?
|
| Nervous System Malformations | 1 | 2005 | 135 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2020 | 15051 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2005 | 272 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2004 | 595 | 0.050 |
Why?
|
| Adaptor Protein Complex alpha Subunits | 1 | 2002 | 2 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2003 | 1218 | 0.050 |
Why?
|
| DNA Transposable Elements | 1 | 2003 | 182 | 0.050 |
Why?
|
| Genotype | 1 | 2008 | 2656 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 657 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2000 | 149 | 0.040 |
Why?
|
| Child | 1 | 2020 | 26307 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2005 | 1101 | 0.040 |
Why?
|
| Calcium | 1 | 2003 | 1041 | 0.040 |
Why?
|
| Pregnancy | 1 | 2011 | 7576 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2014 | 588 | 0.030 |
Why?
|
| Spain | 1 | 2016 | 62 | 0.030 |
Why?
|
| Fucose | 1 | 2016 | 18 | 0.030 |
Why?
|
| Muscles | 1 | 2016 | 222 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 838 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1712 | 0.030 |
Why?
|
| Male | 4 | 2020 | 65274 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 107 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 157 | 0.030 |
Why?
|
| Cricetulus | 1 | 2014 | 88 | 0.030 |
Why?
|
| CHO Cells | 1 | 2014 | 149 | 0.030 |
Why?
|
| Cricetinae | 1 | 2014 | 367 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2015 | 350 | 0.030 |
Why?
|
| Biopsy | 1 | 2016 | 1252 | 0.020 |
Why?
|
| Alleles | 2 | 2008 | 1711 | 0.020 |
Why?
|
| Exons | 1 | 2015 | 769 | 0.020 |
Why?
|
| Receptors, Serotonin, 5-HT1 | 2 | 2003 | 6 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2011 | 286 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 1745 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 1502 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 945 | 0.020 |
Why?
|
| Female | 2 | 2020 | 71214 | 0.020 |
Why?
|
| Spodoptera | 1 | 2008 | 28 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2008 | 54 | 0.020 |
Why?
|
| Solubility | 1 | 2008 | 118 | 0.020 |
Why?
|
| Chromosomes | 1 | 2008 | 119 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2008 | 203 | 0.020 |
Why?
|
| Serine | 1 | 2008 | 163 | 0.020 |
Why?
|
| Cytosol | 1 | 2007 | 140 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 209 | 0.020 |
Why?
|
| Eye | 1 | 2008 | 227 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2008 | 224 | 0.020 |
Why?
|
| Cyclin E | 1 | 2005 | 32 | 0.010 |
Why?
|
| Homozygote | 1 | 2008 | 549 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2008 | 832 | 0.010 |
Why?
|
| Ataxins | 1 | 2005 | 111 | 0.010 |
Why?
|
| Rats | 2 | 2003 | 3460 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2006 | 282 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 1069 | 0.010 |
Why?
|
| Ataxin-1 | 1 | 2005 | 161 | 0.010 |
Why?
|
| Point Mutation | 1 | 2006 | 339 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2007 | 567 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 414 | 0.010 |
Why?
|
| Xenopus | 1 | 2004 | 103 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2004 | 59 | 0.010 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2003 | 5 | 0.010 |
Why?
|
| Purkinje Cells | 1 | 2005 | 170 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 659 | 0.010 |
Why?
|
| Meiosis | 1 | 2003 | 112 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2005 | 598 | 0.010 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2005 | 259 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 265 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 786 | 0.010 |
Why?
|
| Cerebellum | 1 | 2005 | 462 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 1202 | 0.010 |
Why?
|
| Septum of Brain | 1 | 2000 | 5 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2000 | 274 | 0.010 |
Why?
|
| Adult | 1 | 2017 | 31700 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 2000 | 469 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2003 | 2860 | 0.010 |
Why?
|
| Anxiety Disorders | 1 | 2000 | 744 | 0.010 |
Why?
|
| Brain | 1 | 2003 | 3235 | 0.010 |
Why?
|